Microbial Enantioselective Ester Hydrolysis for the Preparation of Optically Active 4,1-Benzoxazepine-3-acetic Acid Derivatives as Squalene Synthase Inhibitors
Microbial enantioselective ester hydrolysis for the preparation of optically active (3R, 5S)-(−)-5-phenyl-4,1-benzoxazepine-3-acetic acid derivatives as potent squalene synthase inhibitors was investigated. Pseudomonas diminuta and Pseudomonas taetrolens hydrolyzed the racemic ethyl ester of the 5-(...
Saved in:
Published in: | Chemical & pharmaceutical bulletin Vol. 50; no. 1; pp. 59 - 65 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Tokyo
The Pharmaceutical Society of Japan
2002
Maruzen Japan Science and Technology Agency |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Microbial enantioselective ester hydrolysis for the preparation of optically active (3R, 5S)-(−)-5-phenyl-4,1-benzoxazepine-3-acetic acid derivatives as potent squalene synthase inhibitors was investigated. Pseudomonas diminuta and Pseudomonas taetrolens hydrolyzed the racemic ethyl ester of the 5-(2-chlorophenyl) analogue to yield the (−)-carboxylic acid with excellent enantiomeric excess (>99% ee). We found that the (−)-enantiomer was an active inhibitor. Bulkiness of the ester moiety did not affect the enantioselectivity but did affect reac-tivity. The racemic ethyl ester of the 5-(2-methoxyphenyl) analogue, 5-(2,3-dimethoxyphenyl) analogue and 5-(2,4-dimethoxyphenyl) analogue were also hydrolyzed with Pseudomonas taetrolens to afford enantiomerically pure (−)-carboxylic acids in large scale. As another route to (3R,5S)-(−)-7-chloro-5-(2,3-dimethoxyphenyl)-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetic acid [(−)-1c], the earlier intermediate (−)-2-amino-5-chloro-α-(2,3-dimethoxyphenyl)benzyl alcohol [(−)-12] was successfully obtained by asymmetric hydrolysis of (±)-5-chloro-α-(2,3-dimethoxyphenyl)-2-pivaloylaminobenzyl acetate with Pseudomonas sp. S-13 with >99% ee in kilogram scale followed by alkaline treatment. The product (−)-12 was converted to (−)-1c without racemization. |
---|---|
AbstractList | Microbial enantioselective ester hydrolysis for the preparation of optically active (3R,5S)-(-)-5-phenyl-4,1-benzoxazepine-3-acetic acid derivatives as potent squalene synthase inhibitors was investigated. Pseudomonas diminuta and Pseudomonas taetrolens hydrolyzed the racemic ethyl ester of the 5-(2-chlorophenyl) analogue to yield the (-)-carboxylic acid with excellent enantiomeric excess (>99% ee). We found that the (-)-enantiomer was an active inhibitor. Bulkiness of the ester moiety did not affect the enantioselectivity but did affect reactivity. The racemic ethyl ester of the 5-(2-methoxyphenyl) analogue, 5-(2,3-dimethoxyphenyl) analogue and 5-(2,4-dimethoxyphenyl) analogue were also hydrolyzed with Pseudomonas taetrolens to afford enantiomerically pure (-)-carboxylic acids in large scale. As another route to (3R,5S)-(-)-7-chloro-5-(2,3-dimethoxyphenyl)-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetic acid [(-)-1c], the earlier intermediate (-)-2-amino-5-chloro-alpha-(2,3-dimethoxyphenyl)benzyl alcohol [(-)-12] was successfully obtained by asymmetric hydrolysis of (+/-)-5-chloro-alpha-(2,3-dimethoxyphenyl)-2-pivaloylaminobenzyl acetate with Pseudomonas sp. S-13 with >99% ee in kilogram scale followed by alkaline treatment. The product (-)-12 was converted to (-)-1c without racemization. Microbial enantioselective ester hydrolysis for the preparation of optically active (3R,5S)-(-)-5-phenyl-4,1-benzoxazepine-3-acetic acid derivatives as potent squalene synthase inhibitors was investigated. Pseudomonas diminuta and Pseudomonas taetrolens hydrolyzed the racemic ethyl ester of the 5-(2-chlorophenyl) analogue to yield the (-)-carboxylic acid with excellent enantiomeric excess (>99% ee). We found that the (-)-enantiomer was an active inhibitor. Bulkiness of the ester moiety did not affect the enantioselectivity but did affect reactivity. The racemic ethyl ester of the 5-(2-methoxyphenyl) analogue, 5-(2,3-dimethoxyphenyl) analogue and 5-(2,4-dimethoxyphenyl) analogue were also hydrolyzed with Pseudomonas taetrolens to afford enantiomerically pure (-)-carboxylic acids in large scale. As another route to (3R,5S)-(-)-7-chloro-5-(2,3-dimethoxyphenyl)-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetic acid [(-)-1c], the earlier intermediate (-)-2-amino-5-chloro-alpha-(2,3-dimethoxyphenyl)benzyl alcohol [(-)-12] was successfully obtained by asymmetric hydrolysis of (+/-)-5-chloro-alpha-(2,3-dimethoxyphenyl)-2-pivaloylaminobenzyl acetate with Pseudomonas sp. S-13 with >99% ee in kilogram scale followed by alkaline treatment. The product (-)-12 was converted to (-)-1c without racemization. Microbial enantioselective ester hydrolysis for the preparation of optically active (3R, 5S)-(-)-5-phenyl-4,1-benzoxazepine-3-acetic acid derivatives as potent squalene synthase inhibitors was investigated. Pseudomonas diminuta and Pseudomonas taetrolens hydrolyzed the racemic ethyl ester of the 5-(2-chlorophenyl) analogue to yield the (-)-carboxylic acid with excellent enantiomeric excess (>99% ee). We found that the (-)-enantiomer was an active inhibitor. Bulkiness of the ester moiety did not affect the enantioselectivity but did affect reac-tivity. The racemic ethyl ester of the 5-(2-methoxyphenyl) analogue, 5-(2,3-dimethoxyphenyl) analogue and 5-(2,4-dimethoxyphenyl) analogue were also hydrolyzed with Pseudomonas taetrolens to afford enantiomerically pure (-)-carboxylic acids in large scale. As another route to (3R,5S)-(-)-7-chloro-5-(2,3-dimethoxyphenyl)-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetic acid [(-)-1c], the earlier intermediate (-)-2-amino-5-chloro-α-(2,3-dimethoxyphenyl)benzyl alcohol [(-)-12] was successfully obtained by asymmetric hydrolysis of (±)-5-chloro-α-(2,3-dimethoxyphenyl)-2-pivaloylaminobenzyl acetate with Pseudomonas sp. S-13 with >99% ee in kilogram scale followed by alkaline treatment. The product (-)-12 was converted to (-)-1c without racemization. Microbial enantioselective ester hydrolysis for the preparation of optically active (3R, 5S)-(−)-5-phenyl-4,1-benzoxazepine-3-acetic acid derivatives as potent squalene synthase inhibitors was investigated. Pseudomonas diminuta and Pseudomonas taetrolens hydrolyzed the racemic ethyl ester of the 5-(2-chlorophenyl) analogue to yield the (−)-carboxylic acid with excellent enantiomeric excess (>99% ee). We found that the (−)-enantiomer was an active inhibitor. Bulkiness of the ester moiety did not affect the enantioselectivity but did affect reac-tivity. The racemic ethyl ester of the 5-(2-methoxyphenyl) analogue, 5-(2,3-dimethoxyphenyl) analogue and 5-(2,4-dimethoxyphenyl) analogue were also hydrolyzed with Pseudomonas taetrolens to afford enantiomerically pure (−)-carboxylic acids in large scale. As another route to (3R,5S)-(−)-7-chloro-5-(2,3-dimethoxyphenyl)-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetic acid [(−)-1c], the earlier intermediate (−)-2-amino-5-chloro-α-(2,3-dimethoxyphenyl)benzyl alcohol [(−)-12] was successfully obtained by asymmetric hydrolysis of (±)-5-chloro-α-(2,3-dimethoxyphenyl)-2-pivaloylaminobenzyl acetate with Pseudomonas sp. S-13 with >99% ee in kilogram scale followed by alkaline treatment. The product (−)-12 was converted to (−)-1c without racemization. |
Author | Nakahama, Kazuo Yukimasa, Hidefumi Izawa, Motowo Tarui, Naoki Miki, Takashi Kori, Masakuni Matsumoto, Kiyoharu Nagata, Toshiaki Nagano, Yoichi |
Author_xml | – sequence: 1 fullname: Tarui, Naoki organization: Takeda Chemical Industries, Ltd., Pharmaceutical Research Division – sequence: 2 fullname: Nakahama, Kazuo organization: Takeda Chemical Industries, Ltd., Pharmaceutical Research Division – sequence: 3 fullname: Nagano, Yoichi organization: Takeda Chemical Industries, Ltd., Pharmaceutical Research Division – sequence: 4 fullname: Izawa, Motowo organization: Takeda Chemical Industries, Ltd., Pharmaceutical Research Division – sequence: 5 fullname: Matsumoto, Kiyoharu organization: Takeda Chemical Industries, Ltd., Pharmaceutical Research Division – sequence: 6 fullname: Kori, Masakuni organization: Takeda Chemical Industries, Ltd., Pharmaceutical Research Division – sequence: 7 fullname: Nagata, Toshiaki organization: Takeda Chemical Industries, Ltd., Pharmaceutical Production Division – sequence: 8 fullname: Miki, Takashi organization: Takeda Chemical Industries, Ltd., Pharmaceutical Research Division – sequence: 9 fullname: Yukimasa, Hidefumi organization: Takeda Chemical Industries, Ltd., Pharmaceutical Research Division |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13455364$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11824586$$D View this record in MEDLINE/PubMed |
BookMark | eNpd0dFqFDEUBuAgFbutXvgCEhAFobMmk2Qmc1OodWsLlQrV6-FM5oybZTaZJrPF6cv4qmbZ1QUvklzky8nhPyfkyHmHhLzmbM5zqT-aoZkrNlfVMzLjQpaZynNxRGaMsSrLRSGOyUmMK8ZyxUrxghxzrnOpdDEjv79aE3xjoacLB260PmKPZrSPSBdxxECvpzb4foo20s4HOi6Rfgs4QICEHfUdvRtGa6DvJ3qxeyjPePYJ3ZP_BU84WIeZyMBgUknYln7GYB9hSyOFSO8fNtCjQ3o_uXEJEemNW9rGjj7El-R5B33EV_vzlPy4Wny_vM5u777cXF7cZkaJosoaLVRR5MCbAjGvUHMQ3HBWqVZoKaqubJXsKt10BpjURdvlafFOl6bUbVOKU_J-V3cI_mGDcazXNhrse3DoN7EuueRlUckE3_4HV34TXOqt5rJgIjGdJ_Vhp1K4MQbs6iHYNYSp5qzezqxOM6sVq1WV7Jt9xU2zxvYg90NK4N0eQEw5dwGcsfHghFQphG1r5zu3iiP8xH8AQkq-x79f8v1WHS6WEGp04g8gFrkJ |
CODEN | CPBTAL |
CitedBy_id | crossref_primary_10_1021_op2001673 crossref_primary_10_1002_chin_200229174 crossref_primary_10_1021_jm020234o crossref_primary_10_1016_j_bmc_2004_08_033 |
Cites_doi | 10.1016/0006-291X(86)90285-8 10.1248/cpb.50.53 10.1271/bbb.57.1334 10.1002/chin.199749337 10.1016/S0076-6879(85)10068-6 10.1021/cr00013a016 10.1002/chin.199549034 |
ContentType | Journal Article |
Copyright | 2002 The Pharmaceutical Society of Japan 2002 INIST-CNRS Copyright Japan Science and Technology Agency 2002 |
Copyright_xml | – notice: 2002 The Pharmaceutical Society of Japan – notice: 2002 INIST-CNRS – notice: Copyright Japan Science and Technology Agency 2002 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7TM 7U9 H94 7X8 |
DOI | 10.1248/cpb.50.59 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Virology and AIDS Abstracts Neurosciences Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1347-5223 |
EndPage | 65 |
ExternalDocumentID | 3133471571 10_1248_cpb_50_59 11824586 13455364 article_cpb_50_1_50_1_59_article_char_en |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 29B 2WC 3O- 53G 5GY 6J9 AABQG AAUGY ABTAH ACGFO ACIWK ACPRK ADBBV AENEX AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP CS3 DIK DU5 E3Z EBS EJD F5P GX1 HH5 JMI JSF JSH KQ8 L7B MOJWN OK1 P2P RJT RZJ TKC TR2 VH1 X7J X7M XSB ZE2 ZGI ZY4 ABMYL AHPSJ ANFDX IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7TM 7U9 H94 7X8 |
ID | FETCH-LOGICAL-c5369-b835662a1b6ee29e81a31c1095d38439f7d54f98bfca0486df26df1f87c78db73 |
ISSN | 0009-2363 |
IngestDate | Sat Aug 17 01:43:15 EDT 2024 Thu Oct 10 18:27:22 EDT 2024 Fri Aug 23 01:40:33 EDT 2024 Sat Sep 28 08:39:11 EDT 2024 Tue Mar 12 05:32:04 EDT 2024 Thu Aug 17 20:28:50 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Pseudomonadales Enantioselectivity Enzyme Transferases Lactam Enzyme inhibitor Screening test Farnesyl-diphosphate farnesyltransferase In vitro Cholesterol Pseudomonas taetrolens Asymmetric synthesis Carboxylic acid Chlorine Organic compounds Bicyclic compound Bacteria Pseudomonadaceae Aromatic compound Chemical synthesis Enantiomer(-) Antilipemic agent Oxygen nitrogen heterocycle Enzymatic reaction |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5369-b835662a1b6ee29e81a31c1095d38439f7d54f98bfca0486df26df1f87c78db73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/cpb/50/1/50_1_59/_article/-char/en |
PMID | 11824586 |
PQID | 1460341782 |
PQPubID | 1996362 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_71417694 proquest_journals_1460341782 crossref_primary_10_1248_cpb_50_59 pubmed_primary_11824586 pascalfrancis_primary_13455364 jstage_primary_article_cpb_50_1_50_1_59_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2002 2002-Jan 2002-00-00 20020101 |
PublicationDateYYYYMMDD | 2002-01-01 |
PublicationDate_xml | – year: 2002 text: 2002 |
PublicationDecade | 2000 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Chemical & pharmaceutical bulletin |
PublicationTitleAlternate | Chem. Pharm. Bull. |
PublicationYear | 2002 |
Publisher | The Pharmaceutical Society of Japan Maruzen Japan Science and Technology Agency |
Publisher_xml | – name: The Pharmaceutical Society of Japan – name: Maruzen – name: Japan Science and Technology Agency |
References | 2) Santaniello E., Ferraboschi P., Grisenti P., Manzocchi A., Chem. Rev., 92, 1071—1140 (1992); Mori K., Synlett, 1995, 1097—1109 (1995); Robert S. M., J. Chem. Soc., Perkin Trans. 1, 1998, 157—169 and 1999, 1—12; Whitesides G. M., Wong C.-H., Angew. Chem., Int. Ed. Engl., 24, 617—718 (1985), for review. 10) Yanase H., Arishima T., Kita K., Nagai J., Mizuno S., Takuma Y., Endo K., Kato N., Biosci. Biotech. Biochem., 57, 1334—1337 (1993). 14) Although optically active 2-amino-5-chloro-α-(2,3-dimethoxyphenyl)benzyl alcohol derivatives are valuable intermediates for the production of drugs and other chemicals, few reports are available on their synthesis: a) Oishi T., Akita H., Kato M., JP 03-22992 (1991) [Chem. Abstr., 115, 157162 (1991)]; b) Kato M., Sasahara K., Ochi K., Akita H., Oishi T., Chem. Pharm. Bull., 39, 2498—2501 (1991); c) Shieh W.-C., Cantrell W. R., Carlson J. A., Tetrahedron Lett., 36, 3797—3800 (1995); d) Nozaki K., Kobori K., Uemura T., Tsutsumi T., Takaya H., Hiyama T., Bull. Chem. Soc. Jpn., 72, 1109—1113 (1999); e) Sakaguchi T., Imai T., Miura T., Yamazaki T., Okada T., JP 09-235255 (1997) [Chem. Abstr., 127, 262513 (1997)]. 3) Sakamoto K., Tsuzaki K., Shima M., JP 09308497 (1997), [Chem. Abstr., 128, 74400 (1997)]. 4) Ozaki E., Uragaki T., JP 09059217 (1997), [Chem. Abstr., 126, 277200 (1997)]. 12) The optical purities of the unreacted esters obtained simultaneously were not determined. 1) Part 4 in the series of studies on 4,1-benzoxazepine derivatives as squalene synthase inhibitors: a) Part 1: Miki T., Kori M., Fujishima A., Mabuchi H., Tozawa R., Nakamura M., Sugiyama Y., Yukimasa H., Bioorg. Med. Chem., 10, 385—400 (2002); b) Part 2: Miki T., Kori M., Mabuchi H., Banno H., Tozawa R., Nakamura M., Itokawa S., Sugiyama Y., Yukimasa H., ibid., 10, 401—414 (2002); c) Part 3: Miki T., Kori M., Tozawa R., Nakamura M., Sugiyama Y., Yukimasa H., Chem. Pharm. Bull., 50, 53—58 (2002). 9) Isshiki K., Nakashima T., Yoshioka T., Tsunekawa H., Adachi T., Ota T., WO 9405637 (1994), [Chem. Abstr., 121, 9161 (1994)]. 13) Cohen L. H., Griffioen A. M., Wanders R. J. A., Van Roermund C. W. T., Huysmans C. M. G., Princen H. M. G., Biochem. Biophys. Res. Commun., 138, 335—341 (1986). 7) Davisson V. J., Woodside A. B., Poulter C. D., Methods Enzymol., 110, 130—144 (1985). 6) Miyadera A., Imura A., JP 08070887 (1996), [Chem. Abstr., 125, 56411 (1996)]. 11) Nakahama K., Izawa M., Nagano Y., Tarui N., Matsumoto K., Kori M., Kanamaru T., Nagata T., JP 08205889 (1996) [Chem. Abstr., 125, 32076 (1996)]. 5) Ozaki E., Uragaki T., JP 09059211 (1997), [Chem. Abstr., 126, 277199 (1997)]. 7) Ozaki E., Uragaki T., Sakashita K., Ikemoto T., Kobayashi Y., Sakimae A., WO 9534525 (1995), [Chem. Abstr., 124, 260386 (1995)]. 8) Isshiki K., Nakajima T., Terasawa T., Watanabe Y., Tanaka H., Yoshioka T., JP 06319593 (1994), [Chem. Abstr., 122, 131151 (1994)]. 11 YANASE H (10) 1993; 57 12 14 Davisson V. J., Woodside A. B., Pou (15) 1985; 110 1 3 4 5 Cohen L. H., Griffioen A. M., Wande (13) 1986; 138 6 7 8 9 (2) 1992; 92 |
References_xml | – ident: 3 – ident: 12 – ident: 11 – volume: 138 start-page: 335 issn: 0006-291X issue: 1 year: 1986 ident: 13 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/0006-291X(86)90285-8 contributor: fullname: Cohen L. H., Griffioen A. M., Wande – ident: 1 doi: 10.1248/cpb.50.53 – ident: 14 – volume: 57 start-page: 1334 issn: 0916-8451 issue: 8 year: 1993 ident: 10 publication-title: Biosci. Biotech. Biochem. doi: 10.1271/bbb.57.1334 contributor: fullname: YANASE H – ident: 5 doi: 10.1002/chin.199749337 – volume: 110 start-page: 130 issn: 0076-6879 year: 1985 ident: 15 publication-title: Methods Enzymol. doi: 10.1016/S0076-6879(85)10068-6 contributor: fullname: Davisson V. J., Woodside A. B., Pou – volume: 92 start-page: 1071 issn: 0009-2665 issue: 5 year: 1992 ident: 2 publication-title: Chem. Rev. doi: 10.1021/cr00013a016 – ident: 6 – ident: 9 – ident: 7 doi: 10.1002/chin.199549034 – ident: 8 – ident: 4 doi: 10.1002/chin.199749337 |
SSID | ssj0025073 |
Score | 1.6729378 |
Snippet | Microbial enantioselective ester hydrolysis for the preparation of optically active (3R, 5S)-(−)-5-phenyl-4,1-benzoxazepine-3-acetic acid derivatives as potent... Microbial enantioselective ester hydrolysis for the preparation of optically active (3R,5S)-(-)-5-phenyl-4,1-benzoxazepine-3-acetic acid derivatives as potent... Microbial enantioselective ester hydrolysis for the preparation of optically active (3R, 5S)-(-)-5-phenyl-4,1-benzoxazepine-3-acetic acid derivatives as potent... |
SourceID | proquest crossref pubmed pascalfrancis jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 59 |
SubjectTerms | 4,1-benzoxazepine-3-acetic acid Animals asymmetric hydrolysis Azepines - chemistry Azepines - metabolism Azepines - pharmacology Biological and medical sciences Biotechnology Enzyme Inhibitors - chemistry Enzyme Inhibitors - pharmacology Esters Farnesyl-Diphosphate Farnesyltransferase - antagonists & inhibitors Fundamental and applied biological sciences. Psychology Health. Pharmaceutical industry Humans Hydrolysis hypocholestemic agent Industrial applications and implications. Economical aspects Liver - drug effects Liver - enzymology Male Other active biomolecules Production of active biomolecules Pseudomonas - metabolism Pseudomonas sp. S-13 Pseudomonas taetrolens Rats Rats, Sprague-Dawley squalene synthase Stereoisomerism Structure-Activity Relationship Tumor Cells, Cultured |
Title | Microbial Enantioselective Ester Hydrolysis for the Preparation of Optically Active 4,1-Benzoxazepine-3-acetic Acid Derivatives as Squalene Synthase Inhibitors |
URI | https://www.jstage.jst.go.jp/article/cpb/50/1/50_1_59/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/11824586 https://www.proquest.com/docview/1460341782 https://search.proquest.com/docview/71417694 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Chemical and Pharmaceutical Bulletin, 2002, Vol.50(1), pp.59-65 |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLW6wQMSQnxTGMNCaC9tRvOdPEassGnqmKATiJfIiW01gOKoaYH2z_BXubYTpx2agAceGlWJEzc5p9f33tjnIvRCFq8ilAUW2H5meQGEOxGlHP54hHOSQxCSqyK278Ozj9HR2Bv3eq3oUbfvvyIN-wBruXL2H9A2F4Ud8B0why2gDtu_wn1SKGklePJMznEpRK0q3cgJQkoUYTBb0bnQQiTtFMNqzrQEuHYeRaUS3F9XSmkDTvQACNvKWLkWP8iaVeCZWq5FcqbUXvOCDijc2jelIV7LyjW1XKsJVlQKIixmMFAOinJWZIUs7bPpDhu5AknAaraVXs82hcFlbiF5d3GiBwTxpTBJ7OQ0OZavCdTMkPVSdAfeJGdv1QgjinxmTjj5lHxQrSdiIb6LraxHFx1PyHy5blbJtTY9thy3MZNMm3HXCyHE1iuZWzuvBW63-KyNdiNJrod_Xbnit4HF8eRiibzKDv3RYXvCpnj3pUHVTHWEn-L7buDtoGsO2EJZ3uHo5NTkBMAdN8X-5E004lfQ3UvT2ZbLdP0zRA1SDuJmRWpAg-v6K1cHSMpRmt5Gt5oIByeamndQj5V30cG5Bnc1xNNuxV89xAf4vBNPX91DPw1_8WX-YsVf3PEXA38x8Bdv8BcLjg1_seYv9oZXsRdL9uIN9mJS45a9uGUv7th7H128Hk9fHVtNERErh8ceWxmEGEHgEDsLGHNiFtnEtcEGxT51I_DGeUh9j8dRxnMi5Scpd-Bj8yjMw4hmofsA7ZaiZI8QtnM_CkPXy9yAerFNY5eHEO84PA-462Ssj563OKWV1opJZYwNYKYAZuqPUj_uo1AjaJo0pqJtYjebuDsAOIBp66P9Lci7PhqK9dFey4G0sUi1DO1H4KlCINBHz8xhGEPki0FSMrGs09CGBkEMF3iomdNd2o4cz4-Cx3_q-wm6oeokqeTkHtpdzJfsKdqp6XJfEf4XctX3lg |
link.rule.ids | 315,782,786,4030,27934,27935,27936 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Microbial+enantioselective+ester+hydrolysis+for+the+preparation+of+optically+active+4%2C1-benzoxazepine-3-acetic+acid+derivatives+as+squalene+synthase+inhibitors&rft.jtitle=Chemical+%26+pharmaceutical+bulletin&rft.au=TARUI%2C+Naoki&rft.au=NAKAHAMA%2C+Kazuo&rft.au=NAGANO%2C+Yoichi&rft.au=IZAWA%2C+Motowo&rft.date=2002&rft.pub=Maruzen&rft.issn=0009-2363&rft.eissn=1347-5223&rft.volume=50&rft.issue=1&rft.spage=59&rft.epage=65&rft_id=info:doi/10.1248%2Fcpb.50.59&rft.externalDBID=n%2Fa&rft.externalDocID=13455364 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon |